Continuous Infusion of Beta-Lactam Antibiotics in Severe Sepsis: A Multicenter Double-Blind, Randomized Controlled Trial
Publication in refereed journal


Times Cited
Web of Science213WOS source URL (as at 19/09/2020) Click here for the latest count
Altmetrics Information
.

Other information
AbstractBackground. Beta-lactam antibiotics are a commonly used treatment for severe sepsis, with intermittent bolus dosing standard therapy, despite a strong theoretical rationale for continuous administration. The aim of this trial was to determine the clinical and pharmacokinetic differences between continuous and intermittent dosing in patients with severe sepsis.
All Author(s) ListDulhunty JM, Roberts JA, Davis JS, Webb SAR, Bellomo R, Gomersall C, Shirwadkar C, Eastwood GM, Myburgh J, Paterson DL, Lipman J
Journal nameClinical Infectious Diseases
Year2013
Month1
Day15
Volume Number56
Issue Number2
PublisherOxford University Press (OUP): Policy A1 - Oxford Open Option C
Pages236 - 244
ISSN1058-4838
eISSN1537-6591
LanguagesEnglish-United Kingdom
Keywordsclinical outcome; meropenem; pharmacokinetics; piperacillin-tazobactam; ticarcillin-clavulanate
Web of Science Subject CategoriesImmunology; IMMUNOLOGY; Infectious Diseases; INFECTIOUS DISEASES; Microbiology; MICROBIOLOGY

Last updated on 2020-20-09 at 01:31